Weekly Pharma & Life Science News Round-Up: 30th January – 3rd February 2023
A round-up of the latest news from the Pharma & Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 30th January – 3rd February 2023.
Thermo Fisher Scientific to Power All Current U.S. Sites With 100 Percent Renewable Electricity
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announces it will power all of the company’s current U.S. sites with 100 percent renewable electricity by 2026.
Gilead Awards $7.6 Million in Grants to Advance Health Equity in Breast Cancer
Gilead Sciences, Inc. (Nasdaq: GILD) awarded $7.6 million in grant funding to 24 U.S.-based, community organizations through the newly created Toward Health Equity (THE) Oncology Grant™.
Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest
Accenture (NYSE: ACN) has acquired Bionest, a strategy and consulting firm dedicated to addressing complex strategic decisions for leading biopharma organizations across innovative areas of science including precision medicine and diagnostics, oncology, cell & gene therapy (CGT), and rare diseases.
AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials
Adherence specialists AARDEX Group and remote research platform experts in the Clinpal team at Cambridge Cognition have teamed up to provide next-level adherence monitoring during hybrid and decentralized clinical trials (DCTs).
Vistagen Announces Closing of Pherin Pharmaceuticals Acquisition
Vistagen (Nasdaq: VTGN) announces the closing of its acquisition of Pherin Pharmaceuticals, Inc., a privately held drug development company focused on neuropsychiatric and neuroendocrine conditions (Pherin).
Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
With the increasing drug development for novel therapeutics, a growing number of pharmaceutical and biotech companies are seeking clinical manufacturing partners to help meet the demand for complex fill and finish solutions.
CCS Launches Scientific Advisory Council to Accelerate Advancements in Chronic Care Management
CCS announces the launch of its Scientific Advisory Council, which includes four industry leaders who will support CCS in its commitment to redefining patient care at home through a more holistic approach.
Launch of LighthouseAI, an AI-Based Venture Unit to Solve Commercial Regulatory Compliance for the Life Sciences Industry
Pharma Solutions, a leading provider of compliance services in the life sciences industry, announces the establishment of a new corporate venture unit and product suite, LighthouseAI™.
X-Chem and Kymera Expand Existing Partnership
X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced the expansion of its collaboration with Kymera Therapeutics, Inc. (NASDAQ: KYMR).
Aptamer Group partner with BaseCure Therapeutics to develop new targeted gene therapies
Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces a new partnership with BaseCure Therapeutics for the development of Optimer-targeted gene therapies.
Unimed Procurement Services Received Queen’s Award for Enterprise in Prestigious Presentation Ceremony
Leading procurement agency Unimed hosted a prestigious ceremony in its Leicester office on January 19, where the organisation was officially presented with the Queen’s Award for Enterprise in the category of International Trade.
CureVac Named as One of the World’s Most Dynamic Innovators by LexisNexis®
CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), announces its inclusion in the second annual “Innovation Momentum: The Global Top 100” report by LexisNexis®.
Neuraxpharm Announces Closing of Acquisition of Established Products from Sanofi
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces the closing of the previously announced acquisition of two established product portfolios for CNS disorders, pain and vascular diseases from Sanofi.
Kelso Pharma Announces First Product Launch
Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the release to the UK prescription medicines market of Acepiro® (Acetylcysteine) 600mg effervescent tablets.
TOPTICA Acquires Azurlight Systems
Germany-based laser manufacturer TOPTICA Photonics AG has entered into a definitive purchase agreement to acquire the majority of the shares of French fiber laser technology company Azurlight Systems SAS.